Ironwood Pharmaceuticals News

Almirall CEO Eyes $11.6 Billion COPD Market Smokers Fuel

IRWD Launches Constella in Europe

Synergy Pharma rises as analyst starts coverage

IRWD Launches Constella in Europe - Analyst Blog

Ironwood Pharmaceuticals announced that it has launched Constella in Europe

Constella® (linaclotide), the first approved prescription therapy in a new class of treatments for adults with IBS-C, is now available in Europe

Constella®,the first and only medicine approved by the European Commission for the symptomatic treatment of moderate to severe Irritable Bowel Syndrome with Constipation (IBS-C)in adult patients, is now ...

Short Interest In Ironwood Pharmaceuticals Moves 11% Lower

The most recent short interest data has been released by the NASDAQ for the 05/31/2013 settlement date, which shows a 1,876,796 share decrease in total short interest for Ironwood Pharmaceuticals Inc. , to 15,213,886, a decrease of 10.98% since 05/15/2013.

4 Stocks Underperforming Today In The Health Services Industry

TheStreet Ratings group highlights 4 stocks pushing the health services industry lower today.

IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement

IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders

Ironwood Pharmaceuticals Announces Partial Exercise of Underwriters’ Option in Public Offering of Common Stock

Ironwood Pharmaceuticals, Inc. today announced that the underwriters of its previously announced public offering of shares of Class A common stock have partially exercised their option to purchase an additional 704,948 shares at a public offering price of $13.00 per share.

Ironwood Pharmaceuticals, Inc. - Shareholder/Analyst Call

Ironwood Pharmaceuticals, Inc. - Shareholder/Analyst Call

Movers roundup: Facebook, Michael Kors

Among the stock activity stories for Thursday, May 30, from AP Business News: — Facebook Inc. outpaced a broader climb in U.S. markets, with two industry analysts upgrading their rankings on the company, ...

Ironwood Pharma rises following analyst upgrade

Ironwood Pharmaceuticals (IRWD) Shares Cross Above 200 DMA

Wedbush Upgrades Ironwood Pharmaceuticals (IRWD) to Neutral